Soligenix SNGX
NASDAQ SNGX
$0.40 +0.02 (+5.50%)
At close: Aug 21, 2026 · 4:00 PM EDT

Soligenix (SNGX) Gross Profit (2010 - 2023)

Soligenix's (SNGX) quarterly Gross Profit came in at $23266.0 in Q4 2023, down 89.89% YoY from $230203.0 in Q4 2022, and up 16.34% on a QoQ basis from $19999.0 in Q3 2023.

Soligenix (SNGX) Gross Profit (2010 - 2023) Analysis & Trends

Soligenix (SNGX) has 14 years of Gross Profit data on file, last reported at $23266.0 in Q4 2023.

  • Quarterly Gross Profit fell 89.89% year-over-year to $23266.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $23266.0 (down 92.35% YoY) and the FY2023 annual result came in at $97311.0, down 75.56% from the prior year.
  • Gross Profit rose to $23266.0 in Q4 2023, from $19999.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $458150.0 in Q2 2019 to a low of $10507.0 in Q2 2021.
  • A 5-year average of $109601.2 and a median of $59642.5 in 2020 frame the typical range for Gross Profit.
  • Annual changes were most pronounced in 2021 — Gross Profit slumped 92.6% — and 2022, when it jumped 476.16%.
  • Tracing SNGX's Gross Profit over 5 years: stood at $98037.0 in 2019, then fell by 19.08% to $79330.0 in 2020, then plunged by 49.63% to $39955.0 in 2021, then jumped by 476.16% to $230203.0 in 2022, then sank by 89.89% to $23266.0 in 2023.
  • The last three Gross Profit figures came in at $23266.0 (Q4 2023), $19999.0 (Q3 2023), and $22908.0 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Soligenix 6.45 Mn 6.45 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 23,266.00
Dec 31, 2023 23,266.00
Sep 30, 2023 19,999.00
Sep 30, 2023 19,999.00
Jun 30, 2023 22,908.00
Jun 30, 2023 22,908.00
Mar 31, 2023 31,138.00
Mar 31, 2023 31,138.00
Dec 31, 2022 230,203.00
Dec 31, 2022 230,203.00
Sep 30, 2022 36,700.00
Sep 30, 2022 36,700.00
Jun 30, 2022 35,336.00
Jun 30, 2022 35,336.00
Mar 31, 2022 95,850.00
Mar 31, 2022 95,850.00
Dec 31, 2021 39,955.00
Dec 31, 2021 39,955.00
Sep 30, 2021 19,933.00
Sep 30, 2021 19,933.00